Our Pipeline
From a culture kit to a full non-animal testing platform for ophthalmology
| Category | Program | Design | Prototype | Validation | Launch | Timing |
|---|---|---|---|---|---|---|
| Product | OrganoKit, slide type RUO 3D organoid culture kit | Launch 2027 | ||||
| Product | OrganoKit, 96-well type Plate format for higher throughput | 2027– | ||||
| Software | AI Toxicity Fluorescence-based toxicity and viability prediction | Service 2027 | ||||
| Model | Ophthalmic organoids Diabetic retinopathy, retina and cornea models | 2026–2028 | ||||
| Model | Disease models Rheumatoid arthritis synovium, breast cancer | Joint research | ||||
| Device | Automated culture system Automated media exchange and dispensing | Prototype 2028 | ||||
| Regulatory | IVD, CE and FDA readiness Medical device and IVD pathway | 2028–2029 | ||||
In progressPlanned
Ophthalmic organoids
Retinal disease models from patient-derived ocular cells.
Disease models
Rheumatoid arthritis synovium, tri-culture and cancer models.
Automation & service
Automated culture hardware and AI analysis as a service.